TABLE 2.
Estimated human brain concentrations of cathinones compared to the monoamine reuptake transporter and neuronal activity inhibition potencies.
| Cathinones | Human (serum/blood/plasma) (μM) | Brain partitioning factor (BPF) | Estimated human (brain) (μM) | IC50 value at or close to estimated human (brain) |
| 3-MMC | 0.005–9.0A,b,c | x | 0.005–9.0 | hDAT > hNET |
| 4-MMC | 0.05–6.0a,d,E,f | 0.7–6.21,–2,3 | 0.04–37 | hNET > hDAT |
| 4-MEC | 0.1–4.7a,d | 1.5–6.24 | 0.2–29 | hDAT > hNET >> MSRa, MBRa, MNBRa |
| Methylone | 0.01–18a,d,g,h | 1.4–4.55,–6,7 | 0.01–81 | hNET, hDAT >> hSERT |
| Pentedrone | 0.04–1.9a,d,I | 1.68 | 0.06–3.0 | hDAT > hNET |
| α-PVP | 0.01–2.8b,j,K | 0.1–1.84,8,9,10 | 0.001–5.0 | hNET > hDAT |
| MDPV | 0.02–6.9d,L,M,n | 0.8–4.44,11,12 | 0.02–30 | hNET > hDAT >> hSERT >> MSRa, MSRp, MBRa, MNBRa |
Estimated brain concentrations were calculated using human blood, serum (caps), or plasma (bold) concentrations and brain partition factors (BPF) found in literature. All human concentrations were obtained from reports on recreational use (voluntary intake, driving under the influence or accidental non-fatal intoxications). BPFs were based on blood/serum (underlined)/plasma (strikethrough) and brain concentrations of human or rat (bold) data. Estimated brain concentrations for 3-MMC were based on the observation that most BPFs are >1. Small to large differences in effect concentrations for different endpoints are depicted as > or >>, respectively. hDAT, human dopamine reuptake transporter; hNET, human norepinephrine reuptake transporter; hSERT, human serotonin reuptake transporter; MSRa, mean spike rate during acute exposure; MBRa, mean burst rate during acute exposure; MBNRa, mean network burst rate during acute exposure; MSRp, mean spike rate during prolonged exposure. References for serum concentrations: aTurcant et al. (2017), bAdamowicz et al. (2016b), cBackberg et al. (2015), dElliott and Evans (2014), eWood et al. (2010), fCosbey et al. (2013), gdeRoux and Dunn (2017), hCawrse et al. (2012), iWorld Health Organisation [WHO] (2016), jAdamowicz et al. (2016a), kBeck et al. (2016), lKriikku et al. (2011), mThornton et al. (2012), nMarinetti and Antonides (2013). References for BPF calculation: 1Gerace et al. (2014), 2Hadlock et al. (2011), 3Martinez-Clemente et al. (2013), 4Lehmann et al. (2018), 5deRoux and Dunn (2017), 6Lõpez-Arnau et al. (2013), 7Štefková et al. (2017), 8Sykutera et al. (2015), 9Hasegawa et al. (2014), 10Potocka-Banas et al. (2017), 11Wyman et al. (2013), 12Marinetti and Antonides (2013).